NBD-557

For research use only. Not for therapeutic Use.

  • CAT Number: I003204
  • CAS Number: 333352-59-3
  • Molecular Formula: C17H24BrN3O2
  • Molecular Weight: 382.30
  • Purity: ≥95%
Inquiry Now

NBD-557(Cat No.:I003204)is a high-purity small-molecule compound used in HIV research. As a CD4 mimetic, it binds to the gp120 envelope glycoprotein of HIV-1, facilitating the study of viral entry mechanisms. Unlike NBD-556, NBD-557 is modified to enhance binding affinity and improve biological activity, making it a valuable tool for investigating the interaction between HIV-1 gp120 and host cell receptors. It is instrumental in developing therapeutic strategies targeting viral entry, aiding in the discovery of innovative approaches for HIV treatment.


CAS Number 333352-59-3
Synonyms

N/’-(4-bromophenyl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)oxamide

Molecular Formula C17H24BrN3O2
Purity ≥95%
Target HIV
Solubility 10 mM in DMSO
Storage Store at -20°C
IUPAC Name N'-(4-bromophenyl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)oxamide
InChI InChI=1S/C17H24BrN3O2/c1-16(2)9-13(10-17(3,4)21-16)20-15(23)14(22)19-12-7-5-11(18)6-8-12/h5-8,13,21H,9-10H2,1-4H3,(H,19,22)(H,20,23)
InChIKey QQRFLGRIDNNARB-UHFFFAOYSA-N
SMILES CC1(CC(CC(N1)(C)C)NC(=O)C(=O)NC2=CC=C(C=C2)Br)C
Reference

<p style=/line-height:25px/>
<br>[1]. Narumi, Tetsuo et al. CD4 mimics targeting the HIV entry mechanism and their hybrid molecules with a CXCR4 antagonist. Bioorganic & Medicinal Chemistry Letters (2010), 20(19), 5853-5858.
<br>[2]. Sch?n A, Madani N, Klein JC, Hubicki A, Ng D, Yang X, Smith AB 3rd, Sodroski J, Freire E. Thermodynamics of binding of a low-molecular-weight CD4 mimetic to HIV-1 gp120. Biochemistry. 2006 Sep 12;45(36):10973-80.
<br>[3]. Singh IP, Chauthe SK. Small molecule HIV entry inhibitors: Part II. Attachment and fusion inhibitors: 2004-2010. Expert Opin Ther Pat. 2011 Mar;21(3):399-416.
<br>[4]. Zhao Q, Ma L, Jiang S, Lu H, Liu S, He Y, Strick N, Neamati N, Debnath AK. Identification of N-phenyl-N/’-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4. Virology. 2005 Sep 1;339(2):213-25.
</p>

Chemistry Calculators Dilution Calculator
In vivo Formulation Calculator
Molarity Calculator
Molecular Weight Calculator
Reconstitution Calculator

Request a Quote